Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta. Arteaga CL, Koli KM, Dugger TC, Clarke R (1999) J Natl Cancer Inst 91: 46-53 The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer. Ramirez NE, Zhang Z, Madamanchi A, Boyd KL, O'Rear LD, Nashabi A, Li Z, Dupont WD, Zijlstra A, Zutter MM (2011) J Clin Invest 121: 226-37 Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Aslakson CJ, Miller FR (1992) Cancer Res 52: 1399-405 Cytosolic phospholipase A2: targeting cancer through the tumor vasculature. Linkous A, Geng L, Lyshchik A, Hallahan DE, Yazlovitskaya EM (2009) Clin Cancer Res 15: 1635-44 CRBP suppresses breast cancer cell survival and anchorage-independent growth. Kuppumbatti YS, Rexer B, Nakajo S, Nakaya K, Mira-y-Lopez R (2001) Oncogene 20: 7413-9 Targeted inhibition of SRC kinase signaling attenuates pancreatic tumorigenesis. Nagaraj NS, Smith JJ, Revetta F, Washington MK, Merchant NB (2010) Mol Cancer Ther 9: 2322-32 Sensitivity to poly(ADP-ribose) polymerase (PARP) inhibition identifies ubiquitin-specific peptidase 11 (USP11) as a regulator of DNA double-strand break repair. Wiltshire TD, Lovejoy CA, Wang T, Xia F, O'Connor MJ, Cortez D (2010) J Biol Chem 285: 14565-71 Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition. Amorino GP, Freeman ML, Carbone DP, Lebwohl DE, Choy H (1999) Int J Radiat Oncol Biol Phys 44: 399-405 Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta. Du J, Jiang B, Coffey RJ, Barnard J (2004) Mol Cancer Res 2: 233-41 The effects of interferons on the activity of alpha-glycerolphosphate dehydrogenase in benign prostatic hyperplasia cells in primary culture. Hayward S, Cox S, Mitchell I, Hallowes R, Deshpande N, Towler J (1987) J Urol 138: 648-53 Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy. Khabele D, Son DS, Parl AK, Goldberg GL, Augenlicht LH, Mariadason JM, Rice VM (2007) Cancer Biol Ther 6: 795-801 miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway. Riquelme I, Tapia O, Leal P, Sandoval A, Varga MG, Letelier P, Buchegger K, Bizama C, Espinoza JA, Peek RM, Araya JC, Roa JC (2016) Cell Oncol (Dordr) 39: 23-33 Increased efficiency for performing colony formation assays in 96-well plates: novel applications to combination therapies and high-throughput screening. Katz D, Ito E, Lau KS, Mocanu JD, Bastianutto C, Schimmer AD, Liu FF (2008) Biotechniques 44: ix-xiv
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.